Myopia Control With a Innovative Spectacle Lens - A Cessation Study
NCT: NCT06884527 · ACTIVE_NOT_RECRUITING
NCT IDNCT06884527
StatusACTIVE_NOT_RECRUITING
Start Date2025-02-18
Completion2026-11
SponsorEssilor International (INDUSTRY)
First posted
Last updated
Brief Summary
The purpose of this study is to quantify myopic progression following cessation of a innovative spectacle lenses after 3 years' use.
Frequently Asked Questions
What is Myopia Control With a Innovative Spectacle Lens - A Cessation Study?
Myopia Control With a Innovative Spectacle Lens - A Cessation Study is a clinical trial registered under NCT06884527. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06884527?
The current status of NCT06884527 (Myopia Control With a Innovative Spectacle Lens - A Cessation Study) is: ACTIVE_NOT_RECRUITING.
When did Myopia Control With a Innovative Spectacle Lens - A Cessation Study start?
Myopia Control With a Innovative Spectacle Lens - A Cessation Study started on 2025-02-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.